Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism
Completed
Conditions studied: Epilepsy, Epilepsy, Complex Partial
In brief
This study is designed to test the effects of vigabatrin (gamma-vinyl-GABA) an experimental drug used for the treatment of epilepsy. The study will use positron emission tomography (PET scan) to detect areas of the brain receiving increased blood flow and using increased amounts of glucose. Increases in blood flow and glucose use are good indicators of brain activity. Researchers are interested in determining the effects of Vigabatrin on brain blood flow and glucose use.
Key facts
- Study ID
- NCT00001489
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
- People needed
- 20
- Starts
- 1994-10-01
- Expected to finish
- 2000-08-01
- Last updated by the study team
- 2008-03-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institute of Neurological Disorders and Stroke (NINDS) — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.